M Life Sciences III Inc. (NasdaqCM:CMLT) announced that it has entered into agreement for a private placement of 6,666,667 warrants at a price of $1.50 per warrant $10,000,000 and 15,000,000 class A shares at a price of $10 per share for gross proceeds of $150,000,000 for aggregate gross proceeds of $160,000,000 on February 24, 2021. The transaction will include participation from Casdin Capital, LLC, Corvex Management LP, CMLS Holdings III LLC for 6,083,335 warrants, Mr. Henry, Mr. Robins and Dr. Robins for 166,666 warrants each and Mr. Owusu-Kesse for 83,334 warrants. Each warrant entitles the holder to purchase one additional common share at an exercise price of $11.50. The securities to be issued have a hold period of 30 days. The company has granted over-allotment option to the underwriters as part of the transaction. The company will issue additional 11,200,000 warrants for $7,750,000 if over-allotment option is exercised. The warrants are non-redeemable. the transaction is expected to close concurrently with the closing of our initial business combination.